gemfibrozil has been researched along with bexarotene in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Heyman, R; Jow, L; Mukherjee, R; Rosen, J; Strasser, J; Syka, P | 1 |
Heyman, RA; Hoener, P; Jow, L; Mukherjee, R; Paterniti, JR; Strasser, J | 1 |
1 review(s) available for gemfibrozil and bexarotene
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for gemfibrozil and bexarotene
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synergistic activation of the hydratase but not the ApoA1 gene by gemfibrozil and retinoids.
Topics: Aconitate Hydratase; Animals; Apolipoprotein A-I; Bexarotene; Drug Synergism; Gemfibrozil; Gene Expression Regulation, Enzymologic; Male; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Retinoids; Tetrahydronaphthalenes; Transcription Factors | 1996 |
RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo.
Topics: Acyl-CoA Oxidase; Animals; Bexarotene; Cholesterol, HDL; Drug Combinations; Female; Gemfibrozil; Gene Expression Regulation; Hypertriglyceridemia; Hypolipidemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidoreductases; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Signal Transduction; Tetrahydronaphthalenes; Transcription Factors; Transcriptional Activation; Triglycerides | 1998 |